Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/74968
Type: | Patent |
Title: | Altered insulin-like growth factor binding proteins |
Author: | Forbes, B. |
Issue Date: | 2009 |
Assignee: | University of Adelaide |
Contributor: | A.P.T. Patent and Trade Mark Attorneys |
Statement of Responsibility: | Invented by B. Forbes; assigened to University of Adelaide; A.P.T. Patent and Trade Mark Attorneys agent for inventors. |
Abstract: | Altered IGFBPs are able to bind IGF but the release is inhibited by resistance to protease cleavage and/or reduced binding to extracellular matrix (ECM). Alterations have been made in IGFBP-2 to the linker domain in particular and two amino acid motifs found to be important for ECM binding. IGF-1 mediated proliferation of cancer cells have been inhibited by the use of these altered IGFBPs. |
Keywords: | AU 2003/243829 B2 |
Description: | PATENT: B. Forbes (Assignee: University of Adelaide). AU 2003/243829 B2 (PCT/AU2003/000898) filed Jul 11, 2003; published Jan 22, 2004; accepted journal date Oct 23, 2008 |
Patent #: | 2003243829 |
Description (link): | http://www.patentlens.net/patentlens/patent/AU_2003_243829_B2/en/ |
Appears in Collections: | Aurora harvest Molecular and Biomedical Science publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.